Friday, May 2, 2025 - Lunch Symposia | 11:30AM-12:30PM
The Impact of Da Vinci 5 in Lung Resection After Induction Therapy: Evolving Technology for the Evolving Patient
Room: 423-425
Sponsored by: Intuitive
RSVP
Join Intuitive for a lunch symposium to engage in a robust discussion around the evolution of surgical landscape with recent advances in interventions. How do these tools and techniques potentially make surgery safer in the evolving patient? Engage with Drs. Elliot Servais, Nathaniel Evans and Stephanie Chang at this event on Friday, May 2.
Speakers:
- Elliot Servais, Lahey Clinic
- Nathanial Evans, Thomas Jefferson University
- Stephanie Chang, NYU Langone Health
Track: Thoracic
Robotic Assisted Surgery Reimagined: Exploring the Intersection of Economics, Indications, and Stapling Technology
Room: 443-444
Sponsored by: Medtronic
RSVP
This symposium follows a poster presented at STS, which reviewed the Premier database on the economics of bedside stapling. The panel will discuss justifications, indications, and future trends for bedside stapling in robotic-assisted surgery. The faculty will examine specific tissue conditions and complications where a bedside stapling approach may be most effective, ensuring the optimal product is used in an optimal robotic procedure to enhance patient outcomes.
Speakers:
- John F. Lazar, Ascension St. Thomas
- Sudish Murthy, Cleveland Clinic
- Abbas El-Sayed Abbas, Warren Alpert Medical School at Brown University
- Mimi Ceppa, ISUM
- Inderpal S. Sarkaria, UT Southwestern Medical Center
Track: Thoracic
Integrating Immunotherapy in Resectable NSCLC: How To Move From Complexity Toward Clarity
Ballroom 2, Level 5
Supported by: AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.
CME provided by: PVI, PeerView Institute for Medical Education
RSVP
Join the discussion on how to maximize the potential of immunotherapy in resectable lung cancer. In this dynamic PeerView Live educational session, top experts will dissect the latest data on different immunotherapy approaches in resectable stage I-III NSCLC, explore how to translate the rapid clinical advances to improvements in patient care, and address critical questions relevant to thoracic surgeons and the broader multidisciplinary team. Real-world cases will frame debates on how to best integrate immunotherapies into individualized treatment plans for patients with resectable lung cancer, and how to improve multidisciplinary alliances and collaboration. Don’t miss this opportunity to hear diverse perspectives on the present and future of immunotherapy in NSCLC, and get answers to your burning questions. RSVP today and join us in Seattle!
Chair: Stephen R. Broderick, Johns Hopkins University School of Medicine
Speakers:
- Matthew Bott, Memorial Sloan Kettering Cancer Center
- Catherine Shu, Columbia University Medical Center
Track: Thoracic
Friday, May 2, 2025 – Lunch Symposia | 12:00-1:00PM
Resetting the Standard: Transforming Patient Care with Advanced Aortic Technologies
Room: 420-422
Sponsored by: Artivion
Join us for lunch and an expert panel discussion featuring Drs. S. Chris Malaisrie, Shinichi Fukuhara, and Michael Moon, moderated by Dr. William Brinkman. They’ll explore how advanced aortic technologies are transforming patient care, with discussion topics including patient selection and treatment strategies for aortic disease.
Learn More
Moderator: William Brinkman, Baylor Scott & White Health
Speakers:
- S. Chris Malaisrie, Northwestern University – A Data-Driven Valve Strategy For Younger AVR Patients
- Shinichi Fukuhara, University of Michigan Health – The Role of AMDS In ADTI Treatment and Results from the PERSEVERE US IDE Study
- Michael Moon, University of Alberta – Importance of Patient Selection and Reintervention Options with AMDS
Track: Cardiac
Seal the Deal – Real World Tips, Tricks, and Tech to Improve Outcomes
Ballroom 3, Level 5
Sponsored by: Johnson & Johnson MedTech
Presentation of Evidence, initiative from his department in Enhancing recovery after Surgery, and the conclusions to be considered by members of AATS. Discussion to include Prineo as an addition to the surgical bundle in CV Surgery for improved outcomes.
Speakers:
- Ziyad Gunga, Lausanne University Hospital
- Elbert Williams, Icahn School of Medicine at Mount Sinai
Track: Cardiac
What You Need to Know About Mitral Valve Lifetime Management – Durability, EOAs and the MITRIS RESILIA Valve
Room: 447-448
Sponsored by: Edwards Lifesciences
This session will discuss: Should mitral valve replacement age guidelines be lowered due to better bioprosthetic mitral valve durability?; Hemodynamic comparison of two models of bioprosthetic mitral valves under standardized in vitro conditions; Comparative differences on mitral valve-in-valve implantation; The mitral valve developed with your patient’s quality of life in mind.
Speakers:
- Matthew Romano, University of Michigan
- Viktoria Stanova, Institut Universitaire de Cardologie et de Pneumologie de Quebec
- Dee Dee Wang, Naples Comprehensive Health
- Michael Acker, Penn Medicine
Track: Cardiac
Friday, May 2, 2025 – Dinner Symposia | 7:30-8:30PM
Re-introducing Mechanical Heart Valves: A Wake-Up Call for Surgeons to Consider Utilizing MHVs in Young Patients
Hyatt Regency, Level 5, Quinalt Room
Sponsored by: Abbott
Learn about the recent nationwide study on the effectiveness of Mechanical versus Tissue heart valves, and how it might change your perception and practice in treating younger patients.
Speakers:
- Tsuyoshi Kaneko, WashU Medicine
- Evelio Rodriguez, Ascension Saint Thomas
Track: Cardiac
Harnessing Precision with EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care
Hyatt Regency, Level 5, Elwha A Room
Supported by: AstraZeneca
CME provided by: PVI, PeerView Institute for Medical Education
RSVP
Targeted therapy has changed the standards of care in resectable NSCLC exhibiting EGFR mutations and other genomic alterations. Adjuvant EGFR-targeted therapy has a defined role in multimodal treatment of patients with EGFR-mutated stage I-III NSCLC, but a number of questions persist related to biomarker testing, appropriate patient identification, and optimal treatment delivery. Ongoing trials are also exploring an expanded role for EGFR TKIs and other targeted agents in earlier disease stages as well as the potential for neoadjuvant protocols in resectable lung cancer.
In this PeerView Live Seminars & Tumor Board educational symposium, experts in thoracic surgery and medical oncology will discuss the latest need-to-know evidence and provide case-based guidance for maximizing the impact of proper biomarker testing and use of EGFR-directed and other targeted therapies in the care of patients with resectable NSCLC. Join us to refine your strategies for harnessing precision in resectable NSCLC and get answers to your burning questions!
Speakers:
- Catherine Shu, Columbia University Medical Center
- Gavitt Woodard, Yale School of Medicine
Track: Thoracic
Saturday, May 3, 2025 – Surgical Suite | 9:00AM-4:30PM
AtriCure Surgical Suite
Saturday, May 3 - 9:00AM-4:30PM
Sunday, May 4 - 9:00AM-12:30PM
Exhibit Hall
Sponsored by: AtriCure
AtriCure’s Clinical Education team will be available for hands-on training and demonstrations using the CADet simulation models. Physicians will be able to use current technology and performing procedures on these models. No appointment needed.
Track: Multi-Specialty
Saturday, May 3, 2025 – Evening Symposium | 6:15-7:15PM
Connecting the Latest Data to the First Pre-Assembled Aortic Tissue Valved Conduit – KONECT device – Ready to Implant. Learn the Techniques
Hyatt Regency, Level 5, Elwha A Room
Sponsored by: Edwards Lifesciences
This session will discuss: Data from The Cleveland Clinic Foundation, The Hospital of the University of Pennsylvania, Weill Cornell Medical Center; Techniques for a simplified approach to root replacement from Dr. Bavaria; Techniques for a bio-Bentall procedure by Dr. Lawrence.
Speakers:
- Eric Roselli, Cleveland Clinic
- Joseph Bavaria, Jefferson Health
- Nimesh Desai, Penn Medicine
- Kendall Lawrence, Penn Medicine
Track: Cardiac
Sunday, May 4, 2025 – Surgical Suite | 9:00AM-4:30PM
AtriCure Surgical Suite
Saturday, May 3 - 9:00AM-4:30PM
Sunday, May 4 - 9:00AM-12:30PM
Exhibit Hall
Sponsored by: AtriCure
AtriCure’s Clinical Education team will be available for hands-on training and demonstrations using the CADet simulation models. Physicians will be able to use current technology and performing procedures on these models. No appointment needed.
Track: Multi-Specialty
Sunday, May 4, 2025 – Lunch Symposia | 12:00-1:00PM
Resectability in the Era of Neoadjuvant/Periadjuvant Therapy
Ballroom 2, Level 5
Sponsored by: AstraZeneca
RSVP
This program will discuss recent clinical data impacting the determination of resectability and the evolving role of neoadjuvant/perioperative therapy in the multidisciplinary management of early-stage non-small cell lung cancer.
Moderator: Biniam Kidane, University of Manitoba
Speakers:
- Linda W. Martin, University of Virginia
- Brendon Stiles, Montefiore Medical Center
- Jessica Donington, University of Chicago
- Jonathan Spicer, McGill University Health Center
Track: Thoracic
Heart Teams Discuss Strategies to Optimize Lifetime Management
Room: 440-442
Sponsored by: Abbott
Learn about the strategies and the decision-making process heart teams use to optimize the patient’s heart journey. Witness a real-world heart team discussion for patients with valvular heart disease. Review key considerations on how to treat patients for lifetime management.
Moderator: Ibrahim Sultan, University of Pittsburgh School of Medicine
Speakers:
- Evelio Rodriguez, Ascension Saint Thomas
- Andrew Morse, Ascension Saint Thomas
- Derek Serna-Gallegos, UPMC Presbyterian
- Dustin Kliner, UPMC Presbyterian